ZINFAMEL Trademark

Trademark Overview

On Thursday, August 27, 2020, a trademark application was filed for ZINFAMEL with the United States Patent and Trademark Office. The USPTO has given the ZINFAMEL trademark a serial number of 90142012. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 11, 2024. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The ZINFAMEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological diseases, respiratory diseases, cancer and pain; contraceptives in the nature of contraceptive preparations
zinfamel

General Information

Serial Number90142012
Word MarkZINFAMEL
Filing DateThursday, August 27, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 10, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological diseases, respiratory diseases, cancer and pain; contraceptives in the nature of contraceptive preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Monday, August 31, 2020NEW APPLICATION ENTERED
Wednesday, September 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 28, 2020ASSIGNED TO EXAMINER
Wednesday, January 6, 2021NON-FINAL ACTION WRITTEN
Wednesday, January 6, 2021NON-FINAL ACTION E-MAILED
Wednesday, January 6, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 10, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 10, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 5, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 1, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 4, 2022SOU EXTENSION 1 FILED
Monday, April 4, 2022SOU EXTENSION 1 GRANTED
Monday, April 4, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 29, 2023SOU EXTENSION 3 FILED
Wednesday, March 29, 2023SOU EXTENSION 3 GRANTED
Wednesday, April 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 22, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 22, 2022SOU EXTENSION 2 FILED
Thursday, September 22, 2022SOU EXTENSION 2 GRANTED
Saturday, September 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 29, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 3, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 3, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 3, 2023SOU EXTENSION 4 FILED
Tuesday, October 3, 2023SOU EXTENSION 4 GRANTED
Thursday, October 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 3, 2024SOU EXTENSION 5 GRANTED
Wednesday, April 3, 2024SOU EXTENSION 5 FILED
Monday, November 11, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, November 11, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

zinfamel diseases preparations contraceptives contraceptive pain nature respiratory treatment neurological pharmaceutical